Skip to main content
Clinical Trials/NCT02331329
NCT02331329
Completed
N/A

Evaluation of NICOM (Bioreactance) for the Non-invasive Determination of Cardiac Output

Universitätsmedizin Mannheim0 sites41 target enrollmentJuly 2013
ConditionsCardiac Disease

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiac Disease
Sponsor
Universitätsmedizin Mannheim
Enrollment
41
Primary Endpoint
agreement of NICOM and MRT cardiac output measurements
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Cardiac output (CO) is an important parameter in the diagnosis and therapy of cardiac diseases. The current standard methods for the determination of CO, however, are either invasive (e.g. right heart catheterization) or technically expendable and expensive (magnetic resonance tomography, MRT). Therefore, the aim of the study at hand was to evaluate NICOM (bioreactance) as a new method for determinion of CO and to compare this new technique to MRT.

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
June 2014
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joachim Saur

senior physician

Universitätsmedizin Mannheim

Eligibility Criteria

Inclusion Criteria

  • indication for cardiac magnetic resonance imaging

Exclusion Criteria

  • pace maker
  • patient unwilling to participate

Outcomes

Primary Outcomes

agreement of NICOM and MRT cardiac output measurements

Time Frame: at time of inclusion

precision of NICOM cardiac output measurements

Time Frame: at time of inclusion

Similar Trials